Clinical trial

REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study

NCT00485069

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-06-01

PhasePHASE4

Study timeline

Study start (unknown)2007-06-01Date precision: month

Registry last updated2010-12-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Parkinson's Diseaseunresolved

Interventions

ROPDRUG

ROP+L-DopaDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

OsakaJapan5 TokyoJapan3 FukuokaJapan3 KyotoJapan1 ChibaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00485069 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.